Tong J - Search Results

1

Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.

Yu W, Chen Y, Xiang R, Xu W, Wang Y, Tong J, Zhang N, Wu Y, Yan H. Yu W, et al. Among authors: tong j. Leuk Lymphoma. 2017 Feb;58(2):428-437. doi: 10.1080/10428194.2016.1190968. Epub 2016 Jul 20. Leuk Lymphoma. 2017. PMID: 27439454

2

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.

Xiang RF, Wang Y, Zhang N, Xu WB, Cao Y, Tong J, Li JM, Wu YL, Yan H. Xiang RF, et al. Among authors: tong j. Cell Death Dis. 2017 May 11;8(5):e2776. doi: 10.1038/cddis.2017.188. Cell Death Dis. 2017. PMID: 28492559 Free PMC article.

3

Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway.

Tong J, Yu Q, Xu W, Yu W, Wu C, Wu Y, Yan H. Tong J, et al. Cancer Biol Ther. 2019;20(3):381-390. doi: 10.1080/15384047.2018.1529112. Epub 2018 Oct 25. Cancer Biol Ther. 2019. PMID: 30359543 Free PMC article.

4

Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy.

Tong J, Xu X, Zhang Z, Ma C, Xiang R, Liu J, Xu W, Wu C, Li J, Zhan F, Wu Y, Yan H. Tong J, et al. Haematologica. 2020 Jun;105(6):1630-1640. doi: 10.3324/haematol.2019.218289. Epub 2019 Jul 9. Haematologica. 2020. PMID: 31289203 Free PMC article.

5

Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells.

Xu X, Huang L, Zhang Z, Tong J, Mi J, Wu Y, Zhang C, Yan H. Xu X, et al. Among authors: tong j. Life Sci. 2019 Jun 15;227:153-165. doi: 10.1016/j.lfs.2019.04.034. Epub 2019 Apr 17. Life Sci. 2019. PMID: 31004657

6

Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia.

Du X, Tong J, Lu H, He C, Du S, Jia P, Zhao W, Xu H, Li J, Shen Z, Wu Y, Tong J, Zhou L. Du X, et al. Among authors: tong j. Mol Med Rep. 2017 Jul;16(1):101-108. doi: 10.3892/mmr.2017.6554. Epub 2017 May 9. Mol Med Rep. 2017. PMID: 28487980 Free PMC article.

7

Risk Assessment Prior to Cardiotoxic Anticancer Therapies in 7 Steps.

Tong J, Senechal I, Ramalingam S, Lyon AR. Tong J, et al. Br J Hosp Med (Lond). 2025 Jan 24;86(1):1-21. doi: 10.12968/hmed.2024.0632. Epub 2025 Jan 24. Br J Hosp Med (Lond). 2025. PMID: 39862029 Review.

8

ACSL1 Aggravates Thromboinflammation by LPC/LPA Metabolic Axis in Hyperlipidemia Associated Myocardial Ischemia-Reperfusion Injury.

Jiang S, Lin X, Chen B, Chen G, Kwan KJS, Liu J, Sun Q, Wang J, Lu Y, Tong J, Deng Y, Yu B, Tang J. Jiang S, et al. Among authors: tong j. Adv Sci (Weinh). 2025 Jan 23:e2406359. doi: 10.1002/advs.202406359. Online ahead of print. Adv Sci (Weinh). 2025. PMID: 39853712

9

Sex- and trimester-specific impact of gestational co-exposure to organophosphate esters and phthalates on insulin action among preschoolers: Findings from the Ma'anshan birth cohort.

Gan H, Lu M, Tong J, Li H, Zhou Q, Han F, Wang X, Yan S, Huang K, Wang Q, Wu X, Zhu B, Gao H, Tao F. Gan H, et al. Among authors: tong j. Environ Int. 2025 Jan 18;196:109287. doi: 10.1016/j.envint.2025.109287. Online ahead of print. Environ Int. 2025. PMID: 39848094

10

ROS-differentiated release of Apelin-13 from hydrogel comprehensively treats myocardial ischemia-reperfusion injury.

Zhen P, Jiang Q, Yu F, Xu X, Wei Q, Liu X, Sun X, Liang G, Tong J. Zhen P, et al. Among authors: tong j. J Control Release. 2025 Jan 23;379:609-620. doi: 10.1016/j.jconrel.2025.01.039. Online ahead of print. J Control Release. 2025. PMID: 39842726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,386 results

Search Page

Filters